- IGC Pharma (IGC, Financial) to host a shareholder call on June 30, 2025, at 11:00 a.m. ET
- Fiscal year 2025 financial results to be released before market opening on the same day
- Replay of the teleconference will be available until July 31, 2025
IGC Pharma, Inc. (IGC), a clinical-stage biotechnology company, has announced an upcoming conference call and webcast scheduled for Monday, June 30, 2025, at 11:00 a.m. Eastern Time. The call will discuss the company's operational progress and financial results for the fiscal year ending March 31, 2025.
The financial results will be unveiled before the market opens on the same day. Shareholders and investors can participate in the conference call by dialing (888) 506 0062 for domestic calls or (973) 528 0011 for international calls and using the access code 370284. An online webcast will also be available, providing a convenient platform for participants.
For those unable to join the live event, a replay of the teleconference will be accessible until July 31, 2025, via the webcast link, ensuring that all interested parties have ample opportunity to review the discussions.
IGC Pharma continues to leverage AI in developing treatments for Alzheimer's and metabolic disorders, with its lead asset IGC-AD1 currently in a Phase 2 trial for agitation in Alzheimer's dementia. The company maintains a robust pipeline targeting amyloid plaques and other neurodegenerative conditions.
